[REGN] QoQ Quarter Result on 30-Sep-2009 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
03-Nov-2009
Financial Year
2009
Quarter
30-Sep-2009 [#Q3]
Profit Trend
QoQ- 93.21%
YoY- 95.19%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Revenue 115,886 103,534 96,800 117,455 90,032 74,981 55,837 62.92%
PBT -23,132 -30,304 -40,611 -1,015 -14,938 -17,481 -32,246 -19.91%
Tax -1,184 218 -4,122 -857 -2,656 -3,500 -728 38.42%
NP -25,474 -30,522 -36,489 -1,015 -14,938 -17,481 -31,518 -13.26%
Tax Rate - - - - - - - -
Total Cost 141,360 134,056 133,289 118,470 104,970 92,462 87,355 37.95%
Ratio Analysis
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
NP Margin -21.98 -29.48 -37.70 -0.86 -16.59 -23.31 -56.45 -46.76%
Per Share
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
EPS -0.31 -0.38 -0.46 -0.01 -0.19 -0.22 -0.40 -15.66%
EPS Diluted -0.31 -0.38 -0.45 -0.01 -0.19 -0.22 -0.40 -15.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.